Recreate vascularized solid tumours to assess therapeutic potency with μMass™
Breakthroughs start with the right tools. µMass™ empowers you to push the boundaries of discovery, performing 56 distinct tests on a single platform with unmatched precision, as well as a 60% reduction of reagent usage. Designed for generating vascularized solid tumours in vitro to quantify cell-therapy potency, and capable of much more—culturing organoids, spheroids, and next-generation organ-on-chip research—it brings you closer to real clinical outcomes.
Whether it’s unravelling disease mechanisms, optimizing drug dosing, or pioneering new therapies, µMass™ makes every experiment count. Fully automation-compatible, it seamlessly integrates into your lab—so you can focus on what truly matters: advancing science and making a real impact on the lives of patients.
Example cellular systems: breast, lung, and prostate cancer as well as many more!
Download the brochure below for a full list of cell types.
Interested in working with cells you don’t see listed? Get in touch!
“The µMass enables the formation of 3D spheroids on the same level as standard low-adhesion plates, however, the µMass enables faster medium exchange without damaging cell models. This results in significant improvement in the comfort and precision of laboratory work, and thus better reproducibility when performing multiple batches of an experiment.”
